Brooks Laboratories Limited (BROOKS.BO)
INR 162.3
(1.98%)
INR 162.3
(1.98%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 794.86 Million | 624.8 Million | 900.93 Million | 770.4 Million | 691.32 Million | 550.3 Million |
| Cost of Revenue | 729.24 Million | 612.21 Million | 757.98 Million | 552.4 Million | 534.76 Million | 454.47 Million |
| Gross Profit | 65.62 Million | 12.59 Million | 142.94 Million | 218 Million | 156.55 Million | 95.82 Million |
| Operating Expenses | 51.18 Million | 348.09 Million | 359.97 Million | 284 Million | 249 Million | 216.88 Million |
| Selling, General and Administrative Expenses | 51.18 Million | 104.31 Million | 91 Million | 68.1 Million | 50.22 Million | 48.06 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 1.07 Million | 1.35 Million | 5.63 Million | 332 Thousand | 1.2 Million |
| Cost and Expenses | 780.42 Million | 960.3 Million | 1.11 Billion | 836.4 Million | 783.76 Million | 671.35 Million |
| Operating Income | 14.44 Million | -338.44 Million | -218.61 Million | -108.43 Million | -95.1 Million | -148.58 Million |
| Interest Expense | 8.44 Million | 19.53 Million | 28.31 Million | 30.98 Million | 33.5 Million | 29.62 Million |
| Income Tax Expense | 259 Thousand | -73.24 Million | -45.85 Million | 103.82 Million | 108.62 Million | -1.42 Million |
| Earnings before Tax | -195.66 Million | -383.78 Million | -238.97 Million | -89.85 Million | -135.13 Million | -149.47 Million |
| Net Income | -195.91 Million | -310.54 Million | -193.12 Million | -193.75 Million | -243.76 Million | -148.05 Million |
| Earnings Per Share Basic | -7.67 | -12.45 | -7.74 | -7.77 | -13.71 | -7.37 |
| Earnings Per Share Diluted | -7.65 | -12.45 | -7.74 | -7.77 | -13.71 | -7.37 |
| Weighted Average Shares Outstanding | 25.54 Million | 24.94 Million | 24.94 Million | 24.94 Million | 17.78 Million | 20.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.61 Million | 24.94 Million | 24.94 Million | 24.94 Million | 17.78 Million | 20.1 Million |
| Gross Margin | 0.08 | 0.02 | 0.16 | 0.28 | 0.23 | 0.17 |
| EBIT Margin | 0.05 | -0.48 | -0.16 | 0.02 | -0.03 | -0.10 |
| Profit Margin | -0.25 | -0.50 | -0.21 | -0.25 | -0.35 | -0.27 |
| EBITDA | 41.72 Million | -291.68 Million | -134.5 Million | 12.52 Million | -35.15 Million | -54.85 Million |
| Earnings Before Tax Margin | 0.02 | -0.54 | -0.24 | -0.14 | -0.14 | -0.27 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 179.32 Million | 794.86 Million | 177.21 Million | 217.46 Million | 243.15 Million | 157.02 Million |
| Cost of Revenue | 157.78 Million | 689.32 Million | 154.51 Million | 154.58 Million | 174.6 Million | 141.95 Million |
| Gross Profit | 21.54 Million | 105.53 Million | 22.7 Million | 62.88 Million | 68.54 Million | 15.07 Million |
| Operating Expenses | 22.74 Million | 91.09 Million | 23.46 Million | 56.26 Million | 55.79 Million | 19.23 Million |
| Selling, General and Administrative Expenses | 22.74 Million | - | 23.46 Million | 23.52 Million | 24.86 Million | 19.23 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 693 Thousand | 9.55 Million | 6.53 Million | 1.55 Million | 921 Thousand | 548 Thousand |
| Cost and Expenses | 180.53 Million | 780.42 Million | 177.97 Million | 210.85 Million | 230.4 Million | 161.19 Million |
| Operating Income | -1.2 Million | 14.44 Million | -759 Thousand | 6.61 Million | 12.74 Million | -4.16 Million |
| Interest Expense | 1.61 Million | 8.44 Million | 2.74 Million | 2.12 Million | 1.86 Million | 1.71 Million |
| Income Tax Expense | 22.01 Million | 259 Thousand | 99.09 Million | 259 Thousand | 921 Thousand | 39.37 Million |
| Earnings before Tax | -2.12 Million | 15.54 Million | 3.03 Million | -38.52 Million | -16.37 Million | -5.32 Million |
| Net Income | -24.13 Million | -195.91 Million | -96.06 Million | -38.78 Million | -16.37 Million | -44.7 Million |
| Earnings Per Share Basic | -0.92 | - | -3.66 | -1.48 | -0.64 | -1.79 |
| Earnings Per Share Diluted | -0.92 | - | -3.66 | -1.48 | -0.64 | -1.79 |
| Weighted Average Shares Outstanding | 26.24 Million | 25.54 Million | 26.24 Million | 26.24 Million | 25.57 Million | 24.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.24 Million | 25.54 Million | 26.24 Million | 26.24 Million | 25.57 Million | 24.94 Million |
| Gross Margin | 0.12 | 0.13 | 0.13 | 0.29 | 0.28 | 0.10 |
| EBIT Margin | 0.02 | - | 0.02 | -0.15 | -0.04 | 0.00 |
| Profit Margin | -0.13 | -0.25 | -0.54 | -0.18 | -0.07 | -0.28 |
| EBITDA | 2.8 Million | - | 3.8 Million | -32.05 Million | -10.09 Million | 245 Thousand |
| Earnings Before Tax Margin | -0.01 | 0.02 | -0.00 | 0.03 | 0.05 | -0.03 |
GB00BL9YR756
3249
6216
RESONANCE
ISOP
BAKPF